Paolo Visca

2.9k citations
74 papers · 1.8k indexed · h-index 25
Topics
Lung Cancer Treatments and Mutations (13 papers)Cancer, Lipids, and Metabolism (8 papers)Lung Cancer Diagnosis and Treatment (7 papers)

In The Last Decade

Paolo Visca

71 papers receiving 1.7k citations

Peers

Paolo Visca
Comparison fields: 5 of 111
  • Molecular Biology 954
  • Cancer Research 777
  • Oncology 419
  • Surgery 300
  • Pulmonary and Respiratory Medicine 242
Replace Ming Song with:
Ming Song China
Rafael Malagoli Rocha Brazil
Matthew J. Martin United States
María Aparecida Nagai Brazil
Su Yin Lim Australia
Zhiyong Mi United States
Hideya Onishi Japan
Ruben R. Plentz Germany
Si‐Rui Ma China
Paolo Visca relative to Ming Song China Ming Song's profile →
Citations per field
00.5×1.6×
Ming Song · 1×
Citations per year

Countries citing papers authored by Paolo Visca

Since Specialization
Citations

This map shows the geographic impact of Paolo Visca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Visca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Visca more than expected).

Fields of papers citing papers by Paolo Visca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Visca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Visca. The network helps show where Paolo Visca may publish in the future.

Co-authorship network of co-authors of Paolo Visca

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Visca. A scholar is included among the top collaborators of Paolo Visca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Visca. Paolo Visca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 9
5 4
6 33
7 10
8 28
9 10
10 53
11 26
12 26
13 62
14 13
15 22
16 10
17 7
18
Role and prognostic significance of CD44s expression in colorectal cancer.
15
19
Cervical dysplasia, ploidy, and human papillomavirus status correlate with loss of Fhit expression.
17
20 271

About Paolo Visca

Paolo Visca is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 74 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Cancer, Lipids, and Metabolism (8 papers) and Lung Cancer Diagnosis and Treatment (7 papers). The work is most often cited by research in Cancer Research (777 citations), Oncology (419 citations) and Molecular Biology (954 citations). Paolo Visca has collaborated with scholars based in Italy, United States and Malaysia. Frequent co-authors include Claudio Botti, Piero Alò, Ugo Di Tondo, Antonella Mangoni, Valeria Sebastiani, R. Perrone Donnorso, Giorgio Trombetta, Marcella Mottolese, Francesco Facciolo and Franca Del Nonno. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026